AMD推出重磅AI芯片挑戰英偉達
格隆匯12月7日|Advanced Micro Devices Inc.推出了新的所謂加速器芯片,將目標瞄準了這個由英偉達控制的新興市場領域。據該公司稱,其產品能夠比競爭對手的產品更快地運行人工智能軟件。該公司週三在加利福尼亞州聖何塞舉行的活動上推出了備受期待的MI300產品陣容。新的AMD芯片擁有超過1500億個晶體管,內存是目前市場領導者英偉達產品H100的2.4倍。AMD表示該公司產品還有相當於英偉達產品1.6倍的內存帶寬,進一步提升了性能。Su表示,這款新芯片在訓練人工智能軟件方面的能力與英偉達的H100相當,但在推理方面要好得多。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.